This site is updated Hourly Every Day

Trending Featured Popular Today, Right Now

Colorado's Only Reliable Source for Daily News @ Marijuana, Psychedelics & more...

Post: OpenAI Whistleblower Suchir Balaji Found Dead In Apartment: What We Know

Picture of Anschutz Medical Campus

Anschutz Medical Campus

AnschutzMedicalCampus.com is an independent website not associated or affiliated with CU Anschutz Medical Campus, CU, or Fitzsimons innovation campus.

Recent Posts

Anschutz Medical Campus

OpenAI Whistleblower Suchir Balaji Found Dead In Apartment: What We Know
Facebook
X
LinkedIn
WhatsApp
Telegram
Threads
Email

Suchir Balaji, a 26-year-old former OpenAI researcher turned whistleblower, died in San Francisco on November 26 in a suspected suicide, according to local authorities.

The San Francisco Police Department said they found Balaji dead inside his apartment on Buchanan Street after being called to the property for a well-being check at around 1 p.m. on November 26, The Mercury News reported.

The past few years have seen dramatic improvements in the capabilities of AI-powered chatbots, like OpenAI’s ChatGPT , which rely on large language models to produce content for users. However, the process has also been controversial with some publishers accusing OpenAI of using copyrighted works without permission, and a number of legal cases are currently ongoing.

Newsweek contacted OpenAI for comment on Saturday via email outside of regular office hours.

The San Francisco medical examiner’s office said it determined Balaji’s cause of death as suicide. Earlier this week, police said there is "currently no evidence of foul play."

Balaji joined OpenAI in 2020 as a researcher, but by 2022 was becoming increasingly concerned about the company’s attitude towards copyright law.

In an October 23 post on X, formerly Twitter , he said : "I was at OpenAI for nearly 4 years and worked on ChatGPT for the last 1.5 of them. I initially didn’t know much about copyright, fair use, etc. but became curious after seeing all the lawsuits filed against GenAI companies.

"When I tried to understand the issue better, I eventually came to the conclusion that fair use seems like a pretty implausible defense for a lot of generative AI products, for the basic reason that they can create substitutes that compete with the data they’re trained on."

Balaji also shared an interview he gave to The New York Times , which is currently suing OpenAI over alleged copyright infringement of the newspaper.In the interview, Balaji said he initially thought "A.I. was a thing that could be used to solve unsolvable problems, like curing diseases and stopping aging." However, over time, he said he soured on OpenAI’s position on copyright law, concluding: "If you believe what I believe, you have to just leave […]

Leave a Reply

Your email address will not be published. Required fields are marked *

You Might Be Interested...

Microdosing 101

Microdosing 101

Kate Schroeder LPC, LMHC, NCC Key points Microdosing should be approached thoughtfully with proper research and guidance. A trained facilitator can help ensure an individual’s

Read More »